Dinaciclib combinations with ABT‐199 or A‐1155463 were effective in MM cell lines that were partially dependent on MCL‐1, probably due to the simultaneous inactivation of MCL‐1 (by dinaciclib) and other antiapoptotic proteins (by BH3 mimetics). This evidence concerns the gene MCL1 and Miyoshi myopathy.